Clik here to view.
bluebird bio Announces Topics for Gene Therapy Day, October Investor...
Thursday, October 6th 2016 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to developing potentially transformative gene...
View ArticleClik here to view.
Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter 2016 and Full...
Thursday, October 6th 2016 at 2:29pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ), will hold a conference call to discuss fiscal 2016 fourth quarter and full year results, Friday,...
View ArticleClik here to view.
Hot Topics Recap: Breast Cancer Awareness Month 2016
Friday, October 7th 2016 at 1:08pm UTC NEW YORK–(BUSINESS WIRE)– Following are the latest Breast Cancer Awareness Month 2016 news releases and story ideas for reporters, bloggers and media outlets:...
View ArticleClik here to view.
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma...
Monday, October 10th 2016 at 6:15am UTC Late-breaking data to be presented at the ESMO 2016 Congress and Published in The New England Journal of Medicine NEW YORK–(BUSINESS WIRE)– Pfizer Inc....
View ArticleClik here to view.
Pfizer Presents Promising New Immunotherapy Combination Data With INLYTA®...
Sunday, October 9th 2016 at 2:30pm UTC Data From a Trial of INLYTA With Pembrolizumab Provides Additional Support for Novel Immunotherapy Combinations in RCC Preliminary Results from an Ongoing Trial...
View ArticleClik here to view.
NeuroMetrix Announces Participation in Discover Blue: New York City Bluetooth...
Monday, October 10th 2016 at 5:04pm UTC WALTHAM, Mass.–(BUSINESS WIRE)– NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported today that it has been selected to showcase Quell® Wearable Pain Relief...
View ArticleClik here to view.
MeiraGTx Expands ALS Gene Therapy Program in Collaboration with Weill Cornell...
Tuesday, October 11th 2016 at 1:32pm UTC Program seeks to treat ALS patients by activating cells’ own quality control mechanisms NEW YORK–(BUSINESS WIRE)– MeiraGTx, a New York and UK based gene...
View ArticleClik here to view.
Kite Pharma to Host Investor Day on October 18, 2016 Spotlighting an...
Tuesday, October 11th 2016 at 12:30pm UTC SANTA MONICA, Calif.–(BUSINESS WIRE)– Kite Pharma, Inc. (Nasdaq:KITE) today announced that it will hold an Investor Day on October 18, 2016 in New York where...
View ArticleClik here to view.
Acorda Named One of the Best Workplaces by Fortune Magazine and Great Place...
Wednesday, October 12th 2016 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) has been named as one of the 100 Best Medium Workplaces based on an independent...
View ArticleClik here to view.
The Medicines Company to Present Data from its Investigational Anesthetic...
Thursday, October 13th 2016 at 11:30am UTC —Data from five abstracts include Phase I and preclinical animal studies accepted as oral and poster presentations— —VERONA Phase II clinical development...
View ArticleClik here to view.
Data from Clinical and Preclinical Trials of CVT-301 for Treatment of OFF...
Thursday, October 13th 2016 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Results from Phase 1, Phase 2a and preclinical studies of CVT-301, an inhaled form of levodopa, have been featured in the...
View ArticleClik here to view.
bluebird bio Provides Update on LentiGlobin™ Programs and Research and...
Thursday, October 13th 2016 at 12:00pm UTC – Consistently demonstrated improved vector copy number (VCN) in transfusion-dependent β-thalassemia (TDT) and severe sickle cell disease (SCD) patient cells...
View ArticleClik here to view.
22nd Century Very Low Nicotine Cigarettes Could Reduce U.S. Smoking Rates by...
Thursday, October 13th 2016 at 1:45pm UTC Leading Scientists Advocate Dramatic Reduction of Nicotine Content in Cigarettes CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT:XXII), a...
View ArticleClik here to view.
Pathway Genomics’ Chief Financial Officer, Kamal Adawi to present at...
Thursday, October 13th 2016 at 2:15pm UTC SAN DIEGO–(BUSINESS WIRE)– Pathway Genomics, an innovative commercial-stage genomics company, announced today that Kamal Adawi, Chief Financial Officer, will...
View ArticleClik here to view.
Enzo Biochem Reports Strong 2016 Operating Results
Thursday, October 13th 2016 at 8:05pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem Inc. (NYSE:ENZ) today reported strong results for the fourth quarter and fiscal year ended July 31, 2016, paced by...
View ArticleClik here to view.
Pall Life Sciences Launches Kleenpak® Presto Sterile Connectors for...
Friday, October 14th 2016 at 12:00pm UTC PORT WASHINGTON, N.Y.–(BUSINESS WIRE)– Pall Life Sciences, a division of global filtration, separation and purification leader Pall Corporation, is pleased to...
View ArticleClik here to view.
22nd Century Group Announces Above-Market Offering for $11.4 Million
Friday, October 14th 2016 at 12:45pm UTC CLARENCE, N.Y.–(BUSINESS WIRE)– 22nd Century Group, Inc. (NYSE MKT: XXII), a plant biotechnology company that is a leader in tobacco harm reduction, announced...
View ArticleClik here to view.
Dr. Reddy’s to Release Q2 FY17 Results on Oct 25, 2016; Earnings Call Slated...
Friday, October 14th 2016 at 4:24pm UTC HYDERABAD, India–(BUSINESS WIRE)– Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) will announce results for the Second Quarter ended September...
View ArticleClik here to view.
Pfizer to Present New Data on XELJANZ® (Tofacitinib Citrate) for Ulcerative...
Saturday, October 15th 2016 at 2:30pm UTC NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE:PFE) announced that three abstracts for XELJANZ® (tofacitinib citrate), being investigated in moderate to severe...
View ArticleClik here to view.
Acorda to Host Conference Call to Discuss Third Quarter 2016 on October 27, 2016
Monday, October 17th 2016 at 11:00am UTC ARDSLEY, N.Y.–(BUSINESS WIRE)– Acorda Therapeutics, Inc. (Nasdaq:ACOR) will host a conference call and webcast to report its third quarter 2016 financial...
View Article